Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

Completed

• Conditions: SARS (Severe Acute Respiratory Syndrome); Surgery; Covid19
• Interventions: Diagnostic Test: SARS-CoV-2 Ab

• Registration Number: NCT04480580
• Lead Sponsor: University of Cagliari

Brief Summary

We have herein analysed the patients admitted to our Department that underwent serologic tests for SARS-CoV-2 either by Ab or RT PCR, to estimate the prevalence of COVID-19 in the setting of a non-dedicated COVID-19 hospital and in a low CoV-2 incidence area, and to evaluate if security measures are necessary for this context.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-30
• Primary Completion: 2020-04-30
• Study Completion: 2020-06-30
• Status Verified: 2020-07
• Study First Submitted: 2020-07-20
• Study First Submitted QC: 2020-07-20
• Last Update Submitted: 2020-07-20
• Study First Posted: 2020-07-21
• Last Update Posted: 2020-07-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients hospitalized during pandemic spread

Exclusion Criteria

• Incomplete data

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Hospitalized patients	SARS-CoV-2 Ab	-

Primary Outcome Measures

Name	Time	Method
Seroprevalence of SARS-CoV-2	3 months	Positivity of specific IgM or IgG

Trial Locations

Locations (1)

AOU Cagliari; 🇮🇹 Cagliari, CA, Italy